Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells

Blood

Volumn 93, Issue 8, 1999, Pages 2679-2687

  Bräuninger, Andreas ^a   Küppers, Ralf ^b   Spieker, Tilmann ^b   Siebert, Reiner ^b   Strickler, John G ^b   Schlegelberger, Brigitte ^b   Rajewsky, Klaus ^b   Hansmann, Martin Leo ^b  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FRAMESHIFT MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GERMINAL CENTER; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0344528777     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.8.2679     Document Type: Article

References (55)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
2. Baddoura FK, Chan WC, Masih AS, Mitchell D, Sun NC, Weisenburger DD: T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol 103:65, 1995
3. Krishnan J, Wallberg K, Frizzera G: T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 18:455, 1994
4. Ramsay AD, Smith WJ, Isaacson PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 12:433, 1988
5. Camilleri-Broet S, Molina T, Audouin J, Tourneau AL, Diebold J: Morphological variability of tumour cells in T-cell-rich B-cell lymphoma. A histopathological study of 14 cases. Virchows Arch 429:243, 1996
6. Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB: T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am J Surg Pathol 16:351, 1992
7. Loke SL, Ho F, Srivastava G, Fu KH, Leung B, Liang R: Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineage. Am J Pathol 140:981, 1992
8. Chan JK, Tsang WY, Ng CS, Wong CS, Lo ES: A study of the association of Epstein-Barr virus with Burkitt's lymphoma occurring in a Chinese population. Histopathology 26:239, 1995
9. Osborne BM, Butler JJ, Pugh WC: The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: Lineage confirmed by JH rearrangement. Am J Surg Pathol 14:933, 1990
10. Scarpa A, Bonetti F, Zamboni G, Menestrina F, Chilosi M: T-cell-rich B-cell lymphoma. Am J Surg Pathol 13:335, 1989
11. De Jong D, Van Gorp J, Sie-Go D, Van Heerde P: T-cell rich B-cell non-Hodgkin's lymphoma: A progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease. Histopathology 28:15, 1996
12. McBride JA, Rodriguez J, Luthra R, Ordonez NG, Cabanillas F, Pugh WC: T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol 20:193, 1996
13. Rodriguez J, Pugh WC, Cabanillas F: T-cell-rich B-cell lymphoma. Blood 82:1586, 1993
14. Schmidt U, Metz KA, Leder LD: T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: Two closely related entities? Br J Haematol 90:398, 1995
15. Delabie J, Ceuppens JL, Vandenberghe P, de Boer M, Coorevits L, De Wolf-Peeters C: The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 82:2845, 1993
16. Kamel OW, Gelb AB, Shibuya RB, Warnke RA: Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Am J Pathol 142:541, 1993
17. Kelsoe G: The germinal center reaction. Immunol Today 16:324, 1995
18. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, Küppers R: Somatic hypermutation in normal and transformed human B cells. Immunol Rev 162:261, 1998
19. Rajewsky K: Clonal selection and learning in the antibody system. Nature 381:751, 1996
20. Küppers R, Rajewsky K, Hansmann ML: Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol 27:1398, 1997
21. Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H: Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79:2520, 1992
22. Niedobitek G, Young LS, Lau R, Brooks L, Greenspan D, Greenspan JS, Rickinson AB: Epstein-Barr virus infection in oral hairy leukoplakia: Virus replication in the absence of a detectable latent phase. J Gen Virol 72:3035, 1991
23. Küppers R, Zhao M, Hansmann ML, Rajewsky K: Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 12:4955, 1993
24. Kanzler H, Küppers R, Hansmann ML, Rajewsky K: Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184:1495, 1996
25. Braeuninger A, Küppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML: Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells [published erratum appeared in Proc Natl Acad Sci USA 94:14211, 1997]. Proc Natl Acad Sci USA 94:9337, 1997
26. Schlegelberger B, Metzke S, Harder S, Zühle-Jenisch R, Zhang Y, Siebert R: Classical and molecular cytogenetics of tumor cells, in Wegner R (ed.): Lab Manual Diagnostic Cytogenetics. New York, NY, Springer Verlag (in press)
27. Betz AG, Milstein C, Gonzalez-Fernandez A, Pannell R, Larson T, Neuberger MS: Elements regulating somatic hypermutation of an immunoglobulin kappa gene: Critical role for the intron enhancer/ matrix attachment region. Cell 77:239, 1994
28. Feddersen RM, Martin DJ, Van Ness BG: The frequency of multiple recombination events occurring at the human Ig kappa L chain locus. J Immunol 144:1088, 1990
29. Klobeck HG, Zachau HG: The human CK gene segment and the kappa deleting element are closely linked. Nucleic Acids Res 14:4591, 1986
30. Küppers R, Hajadi M, Plank L, Rajewsky K, Hansmann ML: Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human. Eur J Immunol 26:1794, 1996
31. Siminovitch KA, Bakhshi A, Goldman P, Korsmeyer SJ: A uniform deleting element mediates the loss of kappa genes in human B cells. Nature 316:260, 1985
32. Lesk AM, Chothia C: Evolution of proteins formed by beta-sheets. II. The core of the immunoglobulin domains. J Mol Biol 160:325, 1982
33. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RS, Dalla-Favera R: BCL-6 protein is expressed in germinal-center B cells. Blood 86:45, 1995
34. Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, Ye BH, Gambacorta M, Pacini R, Baroni CD, Pescarmona E, Anagnostopoulos I, Stein H, Asdrubali G, Martelli MF, Pelicci PG, Dalla-Favera R, Falini B: Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol 148:1543, 1996
35. Goossens T, Klein U, Küppers R: Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci USA 95:2463, 1998
36. Wilson PC, de Bouteiller O, Liu YJ, Potter K, Banchereau J, Capra JD, Pascual V: Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med 187:59, 1998
37. Rudikoff S, Pumphrey JG: Functional antibody lacking a variable-region disulfide bridge. Proc Natl Acad Sci USA 83:7875, 1986
38. Monni O, Joensuu H, Franssila K, Knuutila S: DNA copy number changes in diffuse large B-cell lymphoma - a comparative genomic hybridization study. Blood 87:5269, 1996
39. Han S, Dillon SR, Zheng B, Shimoda M, Schlissel MS, Kelsoe G: V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 278:301, 1997
40. Papavasiliou F, Casellas R, Suh H, Qin XF, Besmer E, Pelanda R, Nemazee D, Rajewsky K, Nussenzweig MC: V(D)J recombination in mature B cells: A mechanism for altering antibody responses. Science 278:298, 1997
41. Rassenti LZ, Kipps TJ: Lack of allelic exclusion in B cell chronic lymphocytic leukemia. J Exp Med 185:1435, 1997
42. Hsu FJ, Levy R: Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 86:3072, 1995
43. van Beizen N, Hupkes PE, Doekharan D, Hoogeveen-Westerveld M, Dorssers LC, van't Veer MB: Detection of minimal disease using rearranged immunoglobulin heavy chain genes from intermediate-and high-grade malignant B cell non-Hodgkins lymphoma. Leukemia 11:1742, 1997
44. Ottensmeier CH, Thompsett AR, Zhu D, Wilkins BS, Sweetenham JW, Stevenson FK: Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 91:4292, 1998
45. Cleary ML, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Levy R: Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44:97, 1986
46. Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Falini B, Delsol G, Isaacson PG, Pileri S, Stein H: Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 337:453, 1997
47. Ohno T, Stribley JA, Wu G, Hinrichs SH, Weisenburger DD, Chan WC: Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med 337:459, 1997
48. Chapman CJ, Mockridge CI, Rowe M, Rickinson AB, Stevenson FK: Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 85:2176, 1995
49. Chapman CJ, Zhou JX, Gregory C, Rickinson AB, Stevenson FK: VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 88:3562, 1996
50. Qin Y, Greiner A, Hallas C, Haedicke W, Müller-Hermelink HK: Intraclonal offspring expansion of gastric low-grade MALT-type lymphoma: evidence for the role of antigen-driven high-affinity mutation in lymphomagenesis. Lab Invest 76:477, 1997
51. Küppers R, Rajewsky K, Braeuninger A, Hansmann ML: L&H cells in lymphocyte-predominant Hodgkin's disease [letter]. N Engl J Med 338:763, 1998
52. Schäble KF, Zachau HG: The variable genes of the human immunoglobulin kappa locus. Biol Chem Hoppe Seyler 374:1001, 1993
53. Matsuda F, Shin EK, Nagaoka H, Matsumura R, Haino M, Fukita Y, Taka-ishi S, Imai T, Riley JH, Anand R, Soeda E, Honjo T: Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet 3:88, 1993
54. Williams SC, Frippiat JP, Tomlinson IM, Ignatovich O, Lefranc MP, Winter G: Sequence and evolution of the human germline V lambda repertoire. J Mol Biol 264:220, 1996
55. Kabat EA, Wu TT, Reid-Miller M, Perry HM, Gottesman KS: Sequences of Proteins of Immunological Interest. US Govt Printing Office, Bethesda, MD, 1987